105 related articles for article (PubMed ID: 8658780)
1. Clinical implication of hormone treatment in postmenopausal kidney transplants.
Hung CJ; Lee PC; Song CM; Chang YT; Tsai MT; Dai YS; Chen EJ; Lei HY; Lee PH; Lee CJ
Transplant Proc; 1996 Jun; 28(3):1548-50. PubMed ID: 8658780
[No Abstract] [Full Text] [Related]
2. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary results of endocrine investigations in postmenopausal osteoporosis (author's transl)].
Franchimont P; Heynen G; Reginster M; Denis F
J Belge Rhumatol Med Phys; 1973 Sep; 28(5):353-62. PubMed ID: 4211093
[No Abstract] [Full Text] [Related]
4. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
Cason Z; Benghuzzi H; Tucci M; England B
Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
6. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
7. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
Blum I; Vered Y; Lifshitz A; Harel D; Blum M; Nordenberg Y; Harsat A; Sulkes J; Gabbay U; Graff E
Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
[TBL] [Abstract][Full Text] [Related]
8. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
Kawai H; Furuhashi M; Suganuma N
Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
11. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
12. Sr and Fe relationship with hormone replacement therapy and bone mineral density.
Unfer TC; Müller EI; de Moraes Flores EM; Dressler VL; da Silva JC; Duarte MM; Emanuelli T
Clin Chim Acta; 2007 Sep; 384(1-2):113-7. PubMed ID: 17618614
[TBL] [Abstract][Full Text] [Related]
13. Influence of acute estrogenic withdrawal on blood calcitonin.
Pansini F; Bettocchi S; Bergamini C; Bianchi A; Ambrosecchia R; Bagni B; Mollica G
Gynecol Obstet Invest; 1984; 18(1):21-6. PubMed ID: 6430757
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the influence of sex hormones on homocysteine concentration in pre- and postmenopausal women].
Bednarek-Tupikowska G; Tupikowski K; Bohdanowicz-Pawlak A; Bidzińska B; Szymczak J; Filus A; Kuliczkowska J; Milewicz A
Pol Merkur Lekarski; 2005 Feb; 18(104):189-91. PubMed ID: 17877128
[TBL] [Abstract][Full Text] [Related]
15. [Bone metabolism, bone density and estrogen levels in perimenopause: a prospective 2-year-study].
Seifert-Klauss V; Laakmann J; Rattenhuber J; Höss C; Luppa P; Kiechle M
Zentralbl Gynakol; 2005 Jun; 127(3):132-9. PubMed ID: 15915390
[TBL] [Abstract][Full Text] [Related]
16. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
18. The relationship between microalbuminuria, left ventricular hypertrophy, retinopathy, and sex hormone status in newly diagnosed hypertensive women.
Apikoglu M; Bulucu F; Demirbas S; Ay SA; Karaman M; Altun B; Balta S; Gokce G; Demirkol S; Yaman H; Saglam K
Clin Exp Hypertens; 2013; 35(5):325-9. PubMed ID: 22950595
[TBL] [Abstract][Full Text] [Related]
19. [Indications for special endocrinologic diagnosis in gynecology].
Breckwoldt M; Schmitt R; Lehmann F; Braendle W
Fortschr Med; 1974 Jun; 92(17):727-31. PubMed ID: 4599297
[No Abstract] [Full Text] [Related]
20. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
Riggs BL
Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
